TrialThe oncologist2024

Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.

Marie V Nelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.